404 related articles for article (PubMed ID: 12050224)
1. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
Lutfallah C; Wang W; Mason JI; Chang YT; Haider A; Rich B; Castro-Magana M; Copeland KC; David R; Pang S
J Clin Endocrinol Metab; 2002 Jun; 87(6):2611-22. PubMed ID: 12050224
[TBL] [Abstract][Full Text] [Related]
2. Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping.
Mermejo LM; Elias LL; Marui S; Moreira AC; Mendonca BB; de Castro M
J Clin Endocrinol Metab; 2005 Mar; 90(3):1287-93. PubMed ID: 15585552
[TBL] [Abstract][Full Text] [Related]
3. Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.
Sakkal-Alkaddour H; Zhang L; Yang X; Chang YT; Kappy M; Slover RS; Jorgensen V; Pang S
J Clin Endocrinol Metab; 1996 Nov; 81(11):3961-5. PubMed ID: 8923844
[TBL] [Abstract][Full Text] [Related]
4. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test.
Pang S; Carbunaru G; Haider A; Copeland KC; Chang YT; Lutfallah C; Mason JI
Clin Endocrinol (Oxf); 2003 Mar; 58(3):323-31. PubMed ID: 12608938
[TBL] [Abstract][Full Text] [Related]
5. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
Chang YT; Zhang L; Alkaddour HS; Mason JI; Lin K; Yang X; Garibaldi LR; Bourdony CJ; Dolan LM; Donaldson DL
Pediatr Res; 1995 Jun; 37(6):820-4. PubMed ID: 7651769
[TBL] [Abstract][Full Text] [Related]
6. A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia.
Pang S; Wang W; Rich B; David R; Chang YT; Carbunaru G; Myers SE; Howie AF; Smillie KJ; Mason JI
J Clin Endocrinol Metab; 2002 Jun; 87(6):2556-63. PubMed ID: 12050213
[TBL] [Abstract][Full Text] [Related]
7. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency.
Johannsen TH; Mallet D; Dige-Petersen H; Müller J; Main KM; Morel Y; Forest MG
J Clin Endocrinol Metab; 2005 Apr; 90(4):2076-80. PubMed ID: 15671104
[TBL] [Abstract][Full Text] [Related]
8. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.
Simard J; Moisan AM; Morel Y
Semin Reprod Med; 2002 Aug; 20(3):255-76. PubMed ID: 12428206
[TBL] [Abstract][Full Text] [Related]
9. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
Zhang L; Sakkal-Alkaddour H; Chang YT; Yang X; Pang S
J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls.
Marui S; Castro M; Latronico AC; Elias LL; Arnhold IJ; Moreira AC; Mendonca BB
Clin Endocrinol (Oxf); 2000 Jan; 52(1):67-75. PubMed ID: 10651755
[TBL] [Abstract][Full Text] [Related]
11. Adrenal steroidogenic function in a black and Hispanic population with precocious pubarche.
Oberfield SE; Mayes DM; Levine LS
J Clin Endocrinol Metab; 1990 Jan; 70(1):76-82. PubMed ID: 2152934
[TBL] [Abstract][Full Text] [Related]
12. Isolated precocious pubarche: an approach.
Balducci R; Boscherini B; Mangiantini A; Morellini M; Toscano V
J Clin Endocrinol Metab; 1994 Aug; 79(2):582-9. PubMed ID: 8045980
[TBL] [Abstract][Full Text] [Related]
13. Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia.
Schneider G; Genel M; Bongiovanni AM; Goldman AS; Rosenfield RL
J Clin Invest; 1975 Apr; 55(4):681-90. PubMed ID: 164481
[TBL] [Abstract][Full Text] [Related]
14. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
Pang SY; Lerner AJ; Stoner E; Levine LS; Oberfield SE; Engel I; New MI
J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
[TBL] [Abstract][Full Text] [Related]
15. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
[TBL] [Abstract][Full Text] [Related]
16. Genetic defects of steroidogenesis in premature pubarche.
Temeck JW; Pang SY; Nelson C; New MI
J Clin Endocrinol Metab; 1987 Mar; 64(3):609-17. PubMed ID: 3029158
[TBL] [Abstract][Full Text] [Related]
17. 3 alpha-Androstanediol glucuronide in premature and normal pubarche.
Riddick LM; Garibaldi LR; Wang ME; Senne AR; Klimah PE; Clark AT; Levine LS; Oberfield SE; Pang SY
J Clin Endocrinol Metab; 1991 Jan; 72(1):46-50. PubMed ID: 1846006
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
Chang YT; Kulin HE; Garibaldi L; Suriano MJ; Bracki K; Pang S
J Clin Endocrinol Metab; 1993 Nov; 77(5):1251-7. PubMed ID: 8077318
[TBL] [Abstract][Full Text] [Related]
19. New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes.
Moisan AM; Ricketts ML; Tardy V; Desrochers M; Mébarki F; Chaussain JL; Cabrol S; Raux-Demay MC; Forest MG; Sippell WG; Peter M; Morel Y; Simard J
J Clin Endocrinol Metab; 1999 Dec; 84(12):4410-25. PubMed ID: 10599696
[TBL] [Abstract][Full Text] [Related]
20. The molecular and clinical spectrum of 3beta-hydroxysteroid dehydrogenase deficiency disorder.
Pang S
Trends Endocrinol Metab; 1998 Feb; 9(2):82-6. PubMed ID: 18406247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
